Gastroenterology
Volume 130, Issue 3 , Pages 665-671 , March 2006

Decrease in Mortality in Lynch Syndrome Families Because of Surveillance

  • Andrea E. de Jong

      Affiliations

    • The Netherlands Foundation for the Detection of Hereditary Tumors, Leiden University Medical Center, Leiden, The Netherlands
    • Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Yvonne M.C. Hendriks

      Affiliations

    • Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Jan H. Kleibeuker

      Affiliations

    • Department of Gastroenterology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands
    • ,
  • Sybrand Y. de Boer

      Affiliations

    • Rijnstate Hospital Arnhem, Arnhem, The Netherlands
    • ,
  • Annemieke Cats

      Affiliations

    • The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Gerrit Griffioen

      Affiliations

    • Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Fokko M. Nagengast

      Affiliations

    • University Medical Center Nijmegen, Nijmegen, The Netherlands
    • ,
  • Frits G. Nelis

      Affiliations

    • Sophia Hospital Zwolle, Zwolle, The Netherlands
    • ,
  • Matti A. Rookus

      Affiliations

    • Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Hans F.A. Vasen

      Affiliations

    • The Netherlands Foundation for the Detection of Hereditary Tumors, Leiden University Medical Center, Leiden, The Netherlands
    • Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationAddress requests for reprints to: H.F.A. Vasen, MD, PhD, The Netherlands Foundation for the Detection of Hereditary Tumors, Leiden University Medical Center, Poortgebouw Zuid, 2333 AA Leiden, The Netherlands; fax: (31) 71 521 2137.

Received 3 August 2005 ,Accepted 16 November 2005.

References 

  1. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer . Nature . 1994;368:258–261
  2. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer . Cell . 1993;75:1027–1038
  3. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer . Nat Genet . 1997;17:271–272
  4. Akiyama Y, Sato H, Yamada T, Nagasaki H, Tsuchiya A, Abe R, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred . Cancer Res . 1997;57:3920–3923
  5. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer . Nature . 1994;371:75–80
  6. Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers (a study of hereditary nonpolyposis colorectal cancer families) . J Clin Oncol . 2001;19:4074–4080
  7. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, De La CA, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes . Int J Cancer . 1999;81:214–218
  8. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis . Gastroenterology . 1996;110:1020–1027
  9. Vasen HF, Sanders EA, Taal BG, Nagengast FM, Griffioen G, Menko FH, et al. The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC) . Int J Cancer . 1996;65:422–425
  10. Watson P , Lynch HT . Extracolonic cancer in hereditary nonpolyposis colorectal cancer . Cancer . 1993;71:677–685
  11. Jarvinen HJ , Mecklin JP , Sistonen P . Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer . Gastroenterology . 1995;108:1405–1411
  12. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer . Gastroenterology . 2000;118:829–834
  13. Rijcken FE , Mourits MJ , Kleibeuker JH , Hollema H , van der Zee AG . Gynecologic screening in hereditary nonpolyposis colorectal cancer . Gynecol Oncol . 2003;91:74–80
  14. Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HF, et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma . Cancer . 2002;94:1708–1712
  15. Vasen HF , Hartog Jager FC , Menko FH , Nagengast FM . Screening for hereditary non-polyposis colorectal cancer (a study of 22 kindreds in The Netherlands) . Am J Med . 1989;86:278–281
  16. Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations (impact on counseling and surveillance) . Gastroenterology . 2004;127:17–25
  17. World Health Organization (WHO). International Classification of Diseases; manual of the international statistical classification of diseases, injuries and causes of death. Volume I. Geneva, Switzerland.
  18. van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, et al. Second cancer risk following Hodgkin’s disease (a 20-year follow-up study) . J Clin Oncol . 1994;12:312–325
  19. Breslow NE , Day NE . Statistical methods in cancer research. Volume II—The design and analysis of cohort studies . IARC Sci Publ . 1987;1–406
  20. Vasen HF , Mecklin JP , Khan PM , Lynch HT . The International Collaborative Group on HNPCC . Anticancer Res . 1994;14:1661–1664
  21. Vasen HF , Watson P , Mecklin JP , Lynch HT . New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC . Gastroenterology . 1999;116:1453–1456
  22. Voskuil DW , Vasen HF , Kampman E , van’t Veer P . Colorectal cancer risk in HNPCC families (development during lifetime and in successive generations. National Collaborative Group on HNPCC) . Int J Cancer . 1997;72:205–209
  23. Vasen HF, Watson P, Mecklin JP, Jass JR, Green JS, Nomizu T, et al. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer . Anticancer Res . 1994;14:1675–1678
  24. Boks DE , Trujillo AP , Voogd AC , Morreau H , Kenter GG , Vasen HF . Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer . Int J Cancer . 2002;102:198–200
  25. Sundermeyer ML , Meropol NJ , Rogatko A , Wang H , Cohen SJ . Changing patterns of bone and brain metastases in patients with colorectal cancer . Clin Colorectal Cancer . 2005;5:108–113
  26. Diergaarde B , Vrieling A , van Kraats AA , van Muijen GNP , Kok FJ , Kampman E . Environmental factors, truncating APC mutations, and HNPCC/associated colorectal tumors . In: Diet, lifestyle, and molecular alterations that drive colorectal carcinogenesis. Thesis . 2004;p. 91–112
  27. Vasen HF , Morreau H , Nortier JW . Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? . Am J Hum Genet . 2001;68:1533–1535

PII: S0016-5085(05)02393-0

doi: 10.1053/j.gastro.2005.11.032

Gastroenterology
Volume 130, Issue 3 , Pages 665-671 , March 2006

Article Tools